Form 4: H.B. Fuller Executive Vice President, Nathan D. Weaver, Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President of H.B. Fuller, Nathan D. Weaver, reports multiple transactions involving company stock, including the acquisition of shares through vesting of stock units and the withholding of shares for tax obligations.
Summary
- Nathan D. Weaver, Executive Vice President at H.B. Fuller, reported several transactions involving the company's common stock on January 24th and 26th, 2025.
- These transactions include the acquisition of shares through the vesting of performance stock units and restricted stock units, as well as the withholding of shares to cover tax liabilities.
- On January 24th, 1,315 performance stock units, 537 and 421 restricted stock units vested, converting into common stock at a price of $62.32 per share.
- Additionally, 45 shares were acquired due to dividend accruals, and 150, 187, and 482 shares were withheld for taxes related to the vesting of stock units.
- On January 26th, 547 restricted stock units vested, converting into common stock at a price of $62.77 per share, with 160 shares withheld for taxes.
- The report also details Mr. Weaver's holdings of various employee stock options and phantom units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as the transactions are routine and expected, reflecting standard executive compensation practices. There are no indications of negative events or concerns.
Positives
- The vesting of stock units indicates that performance and time-based vesting conditions were met.
- The dividend accrual shows a return of value to the executive.
Negatives
- The withholding of shares for taxes reduces the net gain from the vesting of stock units.
Risks
- The report does not indicate any specific risks, but the transactions are subject to market fluctuations.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the executive's holdings and transactions.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, and H.B. Fuller's filing is consistent with these requirements.
- The vesting schedules and option grants are typical for executive compensation packages in similar companies such as 3M, Avery Dennison, and Sherwin-Williams.
- The stock option exercise prices and vesting periods are comparable to those offered by other companies in the specialty chemicals and materials sector.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
- The vesting of stock units may slightly increase the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 01/19/2017 | Date of grant for one of the employee stock option grants. |
| 04/02/2021 | Date of grant for one of the employee stock option grants. |
| 01/24/2020 | Date of grant for one of the employee stock option grants. |
| 01/24/2021 | Date of grant for one of the employee stock option grants. |
| 01/27/2022 | Date of grant for one of the employee stock option grants. |
| 01/24/2023 | Date of grant for one of the employee stock option grants. |
| 01/25/2019 | Date of grant for one of the employee stock option grants. |
| 01/24/2024 | Date of grant for one of the employee stock option grants. |
| 01/26/2018 | Date of grant for one of the employee stock option grants. |
| 01/24/2025 | Date of multiple stock transactions including vesting of stock units and tax withholdings. |
| 01/26/2025 | Date of multiple stock transactions including vesting of stock units and tax withholdings. |
| 01/28/2025 | Date the form was signed. |
Keywords
stock transactions, insider trading, stock options, restricted stock units, performance stock units, H.B. Fuller, executive compensation, Form 4, vesting, dividend accruals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.